Hypothalamic interaction between prostaglandins and catecholamines in promoting gonadotrophin secretion for ovulation.
D000818:Animals; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology*; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology*; D004338:Drug Combinations; D005260:Female; D006062:Gonadotropins / Q000378:metabolism*; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000378:metabolism; D007031:Hypothalamus; D007267:Injections; D010060:Ovulation / Q000187:drug effects*; D010902:Pituitary Gland; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013238:Stereotaxic Techniques
D004338:Drug Combinations; D006062:Gonadotropins; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D001241:Aspirin; D004298:Dopamine